[HTML][HTML] Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)

HT Abdel-Mohsen, MM Anwar, NS Ahmed… - Molecules, 2024 - mdpi.com
Cancer is a complicated, multifaceted disease that can impact any organ in the body.
Various chemotherapeutic agents have a low selectivity and are very toxic when used alone …

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)

H Abdel-Mohsen, M Anwar, N Ahmed… - Molecules (Basel …, 2024 - europepmc.org
Cancer is a complicated, multifaceted disease that can impact any organ in the body.
Various chemotherapeutic agents have a low selectivity and are very toxic when used alone …

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present)

HT Abdel-Mohsen, MM Anwar… - Molecules (Basel …, 2024 - pubmed.ncbi.nlm.nih.gov
Cancer is a complicated, multifaceted disease that can impact any organ in the body.
Various chemotherapeutic agents have a low selectivity and are very toxic when used alone …

[HTML][HTML] Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021–Present)

HT Abdel-Mohsen, MM Anwar, NS Ahmed… - Molecules, 2024 - ncbi.nlm.nih.gov
Cancer is a complicated, multifaceted disease that can impact any organ in the body.
Various chemotherapeutic agents have a low selectivity and are very toxic when used alone …

Recent Advances in Structural Optimization of Quinazoline-Based Protein Kinase Inhibitors for Cancer Therapy (2021-Present).

HT Abdel-Mohsen, MM Anwar, NS Ahmed… - Molecules (Basel …, 2024 - europepmc.org
Cancer is a complicated, multifaceted disease that can impact any organ in the body.
Various chemotherapeutic agents have a low selectivity and are very toxic when used alone …